0ND5.LSE H Lundbeck A/S

Healthcare Oil, Gas & Consumable Fuels London Exchange
- DKK
Market cap
-
P/E
-
P/B
-
ROE
-
Dividend yield
0.02%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2022.

Is 0ND5.LSE undervalued?

Graham number

The Graham number of H Lundbeck A/S cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

H Lundbeck A/S fundamental analysis

No fundamental analysis for H Lundbeck A/S yet.

H Lundbeck A/S stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About H Lundbeck A/S

H. Lundbeck A/S engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally. The company offers Abilify Maintena/ Abilify Asimtufii for schizophrenia and bipolar I disorder in adults; Brintellix/Trintellix to treat depressive disorders; Rexulti/Rxulti to treat major depressive disorder and schizophrenia; Vyepti for migraine prevention; and Ci…

Full company profile